QU

Quantum Base Holdings PLC

IL

Overview

Corporate Details

ISIN(s):
GB00BTXYPJ53
LEI:
9845002F5A9EY5AM4B40
Country:
United Kingdom
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Quantum Base Holdings PLC is a quantum science company specializing in anti-counterfeiting and authentication technology. Its core product, Q-ID®, is a unique and uncopiable 'atomic-level fingerprint' that can be applied to products, packaging, and documents. The technology enables instant verification using any standard smartphone, providing a highly scalable and accessible solution for brand protection, supply chain security, and document verification. The company's solution is designed for low-cost integration with existing printing processes and is deployed through partnerships with global security organizations.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Quantum Base Holdings PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 08:00
Regulatory News Service
Expansion of Key Contract
English 15.5 KB
2025-07-28 08:00
Board/Management Information
Appointment of Non-Executive Director
English 17.0 KB

Automate Your Workflow. Get a real-time feed of all Quantum Base Holdings PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Quantum Base Holdings PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN